This comprehensive resource contains all of the regulatory class exemptions from ERISA s prohibited transaction rules, along with the statutory prohibited transaction exemptions. It includes class exemption grants, amendments, and proposals, and features a section at the end of each class exemption chapter containing the integrated text of all non-superseded or non-revoked exemptions and amendments, as well as all amendments and corrections since publication of the final exemption. The new Fifth Edition of ERISA Class Exemptions has been reorganized for ease of use, consolidating in Volume I the information that practitioners are more likely to use on a daily basis: analysis and full text of the currently effective exemptions. The chapters in Volume I also supply lists of relevant Federal Register notices and other supporting documents. The first volume also includes the proposed exemptions; superseded, replaced, revoked, expired, and withdrawn exemptions; and user aids. The text of Federal Register notices and other supporting documents for the exemptions is contained in Volume II. This important resource also includes: Coverage of exemptions created or amended by the DOL fiduciary investment advice rule Updates to regulatory guidance on the class exemptions, including advisory opinions and related individual exemptions Updates to case law dealing with class exemption issues -------------------------------------------------------------------------------- SUMMARY OF CONTENTS Part 1. Prohibited Transaction Class Exemptions Currently in Effect Part 2. Statutory Prohibited Transaction Exemptions Added by the Pension Protection Act of 2006 Part 3. Proposed Class Exemptions That Have Not Been Granted Part 4. Superseded, Replaced, Revoked, Expired, and Withdrawn Exemptions Part 5. Indexes and User Aids Part 6. Federal Register Notices and Other Agency Documents Part 7. Online Archive Index of Applicants Topical Index Other User Aids

ERISA Class Exemptions, Fifth Edition

Donald J. Myers

Michael B. Richman

Bloomberg Law

This monumental reference deals with both the high-profile cases and the uncelebrated decisions that tend to slip under the radar and fits them into an analytical framework that reveals their true significance. Patents and the Federal Circuit addresses ever-changing issues and developments in substantive patent law, infringement litigation, and procedure. The authors distill the opinions issued by the primary source of governing law on patents, providing convenient, one-source access to controlling case law. The new Thirteenth Edition adds discussion of the following topics: The Supreme Court s decision in SCA Hygiene Products Aktiebolag v. First Quality Baby Products, LLC that laches does not bar damages for patent infringement where the infringement occurred within the 6-year limitations period. The Federal Circuit s en banc decision in Medicines Co. v. Hospira, Inc. regarding the scope of a commercial sale for purposes of the on sale bar. The Supreme Court s holdings in Impression Products v. Lexmark that single-use/no-sale provisions are unenforceable against third parties and that an authorized sale outside the United States exhausts U.S. patent rights. Venue following the Supreme Court s decision in TC Heartland v. Kraft that a corporation resides for purposes of venue only in the state of incorporation. Liability for infringement of multi-component devices following the Supreme Court s decision in Promega Corp. v. Life Technologies Corp. Operation of the so-called patent dance under the Biologics Price Competition and Innovation Act (BPCIA), including discussion of the Supreme Court s decision in Sandoz Inc. v. Amgen Inc. and the Federal Circuit s decision in Amgen Inc. v. Apotex Inc. The Federal Circuit s recognition of an independent patent agent privilege that attaches to some communications between a client and a non-attorney patent agent in In re Queen s University at Kingston. Design patent damages in light of the Supreme Court s holding in Apple Inc. v. Samsung Electronics Co. that the damages award for a design patent need not be the entire product sold but instead may be only a component of that product. This edition also provides new and expanded discussion on the Doctrine of Equivalents and substantial equivalence injury, the relationship between vitiation and the all elements rule, post-Festo rebuttals to prosecution history estoppel, and procedural considerations related to the Doctrine of Equivalents. The Thirteenth Edition also incorporates the following post-Alice decisions on patentability under 35 U.S.C. § 101: Rapid Litig. Mgmt. Ltd. v. CellzDirect, Inc. Enfish, LLC v. Microsoft Corp., Intellectual Ventures I LLC v. Symantec Corp. AMDOCS (Israel) Ltd. V. Openet Telecom, Inc. Bascom Glob. Internet v. AT&amp;T Mobility, LLC Affinity Labs v. Directv The new edition adds a number of cases examining claim construction post-Teva v. Sandoz and enhanced damages post-Halo and Stryker, and incorporates many other important Federal Circuit patent law decisions.

Patents and the Federal Circuit, Thirteenth Edition

ROBERT L. HARMON

Cynthia A. Homan

Laura A. Lydigsen

Intellectual Property

Whistleblowing: The Law of Retaliatory Discharge, Third Edition, 2017 Cumulative Supplement

Nancy M. Modesitt

Janie F. Schulman

Reference

"The new Fourth Edition of this essential trademark resource guides practitioners through the Trademark Trial and Appeal Board's (TTAB) and the federal courts' findings on similarity of products for trademark registration and enforcement. Trademark practitioners who are investigating similarity or dissimilarity of goods at issue can determine, quickly and easily, whether there are any decided cases that have compared with other products the products under consideration by the user, and can find citationsfor all such cases. The book compiles and indexes 88 years of TTAB and federal court decisions on product comparisons and whether likelihood of confusion was found, and allows practitioners to search the book's entire contents electronically on an accompanying CD-ROM. To help practitioners conduct the most complete and efficient search possible of similar products, the authors have analyzed the findings of the courts and/or the Board in order to impose editorial uniformity on the descriptions of productslisted in the cases and have assigned U.S. Class numbers to each product. The Fourth Edition covers TTAB proceedings and court decisions from 1929 through December 2016, and contains more than 90,000 product comparisons, including approximately 1500 comparisons from 2016 alone. The Fourth Edition has been extensively reviewed to refine and reorganize the descriptions and reduce duplicate entries to make it the most complete and effective reference possible. It also includes citations for every comparison, making it easy to find decisions on the Patent and Trademark Office (PTO) website or in Bloomberg BNA's U.S. Patents Quarterly"--

Products Comparison Manual for Trademark Users, Fourth Edition

Francis M. Pinckney

This convenient and easily accessible manual provides in a single volume the information necessary to understand the Department of Labor s views on ERISA, from its regulations and guidance, to its investigatory and enforcement priorities, to its litigation positions. A critical tool for ERISA practitioners, this compilation is also essential to plan sponsors, fiduciaries, and service providers anyone who needs a single, cohesive resource to understand the DOL s jurisdiction and enforcement of ERISA when facing investigations or lawsuits brought by the Department. Rather than having to search through multiple sources to obtain this information, ERISA professionals can now rely on this consolidated guidebook for both advisory and litigation purposes. Written by a former Deputy Associate Solicitor in the Department s national office, ERISA: Department of Labor Investigations, Enforcement, and Litigation provides indispensable insight into the DOL s structure, priorities, and interpretive positions. Highlights featured include: Complete guide to DOL regulations, interpretive bulletins, prohibited transaction exemptions, advisory opinions, field assistance bulletins, and technical releases, and the level of deference the DOL has received from the courts Pension and health plan investigations, including ACA and MEWA enforcement and the DOL s authority to issue cease and desist and summary seizure orders Investigations and litigation under ERISA § 510 Litigation of fiduciary issues under ERISA § 404, prohibited transactions under ERISA § 406, and exemptions under ERISA § 408, including co-fiduciary liability and the liability of knowing participants ESOP litigation The Fiduciary Rule and its status Comprehensive appendix of investigation and litigation-related documents including subpoenas, closing letters, and settlement agreements

ERISA: Department of Labor Investigations, Enforcement, and Litigation

Theresa S. Gee

This treatise offers detailed, annotated coverage of ERISA Titles I and IV; rules of tax qualification, deductibility, and other key tax issues; preemption with regard to ERISA and medical malpractice and related claims; benefit claims with regard to evidentiary issues and abuse of discretion in denials; interplay with related legal areas; and effects of sexual orientation and veteran status on benefits. 
 The Spring 2018 Supplement updates the treatise with coverage current through December 31, 2016, as well as Supreme Court opinions, final regulations, and legislation issued through August 31, 2017. 
 It addresses developments including: opinions that partially stayed or invalidated regulations related to the Affordable Care Act; Supreme Court opinion on the nature of church plans exempt from coverage under ERISA; and circuit split on status of final regulations implementing fiduciary standards for investment advice related to employee benefit plans.

Employee Benefits Law, Fourth Edition, Spring 2018 Supplement

Ivelisse Berio LeBeau

Affordable Care Act: Law and Regulations Annotated, 2018-2019 Edition

ESQ.

Sharon F. Fountain

Eric H. Rubin

Robert W. Clarida

A guide through the minefield of court decisions that have systematically eroded the scope and validity of patents. This treatise helps practitioners draft the broadest possible patent by synthesizing and applying lessons from the case law to sustain a validity challenge. It provides in-depth discussions on pitfalls in claim drafting; dangers of means plus-function clauses in claims; strategies to target direct infringers; the scope of enablement trends; instructions on how to Festo-proof a patent application; and more. The Third Edition is revised to: Update discussions based on evolving post-AIA (Leahy-Smith America Invents Act) case law Analyze evolving case law under 35 U.S.C. §101 and the U.S. Supreme Court s Alice Corp. decision Incorporate Supreme Court decisions on the PTAB s authority and scope of review (Oil States Energy Services, LLC v. Greene s Energy Group, LLC, confirming Congress s authority to create the PTAB trial system, and SAS Institute Inc. v. Iancu. rejecting the USPTO s argument that its practice of partial institutions was unreviewable) Address 2018 USPTO guidance on recent subject matter eligibility decisions The Third Edition also focuses on significant court decisions relating to patent law, including: In Travel Sentry, Inc. v. Tropp, the Federal Circuit noted the importance of correctly identifying the relevant activity or benefit that is being conditioned upon the performance of one or more claim steps An updated discussion on double patenting issues in chemical cases, including discussion of Gilead Sciences, Inc. v. Natco Pharma Ltd., where the Federal Circuit clarified that claims in a later-expiring patent that are obvious over an earlier-expiring patent must be terminally disclaimed or cancelled, regardless of which application was filed first, at least under modern rules of calculating patent term In the context of a biotechnology invention, the Supreme Court clarified the meaning of a substantial portion of the invention in Life Technologies Corp. v. Promega Corp. In Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc., the Federal Circuit interpreted the on-sale bar provisions of the post-AIA version of 35 U.S.C. §102(b); the Supreme Court has granted cert. In re Janssen Biotech, Inc., the Federal Circuit held that an attempt to re-designate a patent issued on a CIP application as a divisional application during reexamination was insufficient to provide the issued patent the benefit of the Section 121 safe harbor The Risk of Inadvertent Misuse of Information Disclosed in Discovery to a Litigator who Performs Other Functions for her Client An extensive discussion of the three step process for determining whether litigators who also prosecute patent applications should be barred from access to the opposing party s highly confidential information Expanded and updated discussions of harmonization of different national approaches to patents, the Unified Patent Court in Europe, and forum shopping when litigating in Europe

Drafting Patents for Litigation and Licensing, Third Edition

Bradley C. Wright

Federal Income Taxation of Insurance Companies, Fourth Edition, 2018 Supplement

Emanuel S. Burstein

See the best price to sell, buy or rent books by the Bloomberg Law publisher. BookScouter helps to compare book prices from 25+ online bookstores and 30+ buyback vendors with a single search.